Dahl EH - Search Results

1

Control of visceral leishmaniasis in East Africa: fragile progress, new threats.

Dahl EH, Hamdan HM, Mabrouk L, Matendechero SH, Mengistie TB, Elhag MS, Lado M, Adera C, Atia AA, Potet J, den Boer M, Ritmeijer K, Alvar J, Alves F, Alcoba G. Dahl EH, et al. BMJ Glob Health. 2021 Aug;6(8):e006835. doi: 10.1136/bmjgh-2021-006835. BMJ Glob Health. 2021. PMID: 34413075 Free PMC article. No abstract available.

2

Leaving no one behind: Towards equitable global elimination of hepatitis C.

Dahl EH, Zahid H, Aslam K, Jafri W. Dahl EH, et al. J Glob Health. 2020 Jun;10(1):010308. doi: 10.7189/jogh.10.010308. J Glob Health. 2020. PMID: 32257136 Free PMC article. No abstract available.

3

DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series.

Zahid H, Aslam K, Dahl EH, Abbassi W, Adan S, Van den Bergh R, Balinska MA, Luck NH. Zahid H, et al. Among authors: dahl eh. Oxf Med Case Reports. 2022 May 23;2022(5):omac049. doi: 10.1093/omcr/omac049. eCollection 2022 May. Oxf Med Case Reports. 2022. PMID: 35619685 Free PMC article.

4

Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries.

Peacocke EF, Heupink LF, Frønsdal K, Dahl EH, Chola L. Peacocke EF, et al. Among authors: dahl eh. BMJ Open. 2021 Sep 30;11(9):e049505. doi: 10.1136/bmjopen-2021-049505. BMJ Open. 2021. PMID: 34593496 Free PMC article. Review.

5

Obligations in a global health emergency.

de Carvalho Borges da Fonseca F, Dahl EH, Menghaney L, Sehoma C, Hu Y. de Carvalho Borges da Fonseca F, et al. Among authors: dahl eh. Lancet. 2021 Dec 4;398(10316):2071. doi: 10.1016/S0140-6736(21)02345-X. Lancet. 2021. PMID: 34863344 Free PMC article. No abstract available.

6

The power of touch.

Dahl EH. Dahl EH. Lancet. 2020 Apr 4;395(10230):e62. doi: 10.1016/S0140-6736(20)30177-X. Lancet. 2020. PMID: 32247398 No abstract available.

7

Hepatitis C treatment and reinfection surveillance among people who inject drugs in a low-threshold program in Oslo, Norway.

Midgard H, Ulstein K, Backe Ø, Foshaug T, Sørli H, Vennesland K, Nilssen D, Dahl EH, Finbråten AK, Wüsthoff L, Dalgard O. Midgard H, et al. Among authors: dahl eh. Int J Drug Policy. 2021 Oct;96:103165. doi: 10.1016/j.drugpo.2021.103165. Epub 2021 Feb 26. Int J Drug Policy. 2021. PMID: 33642182

8

COVID-19 myocarditis and postinfection Bell's palsy.

Dahl EH, Mosevoll KA, Cramariuc D, Vedeler CA, Blomberg B. Dahl EH, et al. BMJ Case Rep. 2021 Jan 11;14(1):e240095. doi: 10.1136/bcr-2020-240095. BMJ Case Rep. 2021. PMID: 33431479 Free PMC article.

9

Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.

Duffell E, Cortez-Pinto H, Simonova M, Dalgard O, Dahl EH, de Martel C, Mozalevskis A, Buti M, Pavlova S, Hadzhilova T, Simões C, Katzarov K, Mardh O. Duffell E, et al. Among authors: dahl eh. J Viral Hepat. 2021 Aug;28(8):1177-1189. doi: 10.1111/jvh.13545. Epub 2021 Jun 8. J Viral Hepat. 2021. PMID: 34003542 Free PMC article.

10

Aluminium accumulation and immunosuppressive effect in recipients of kidney transplants.

Nordal KP, Dahl E, Albrechtsen D, Halse J, Leivestad T, Tretli S, Flatmark A. Nordal KP, et al. BMJ. 1988 Dec 17;297(6663):1581-2. doi: 10.1136/bmj.297.6663.1581. BMJ. 1988. PMID: 3147082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page